Voya Financial Advisors, Inc. Repligen Corp Transaction History

Voya Financial Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $340,862 - $454,052	-2,055 Closed	0 $0
Q4 2020 Mar 05, 2021	BUY	$148.08 - $206.57 $8,144 - $11,361	55 Added 2.75%	2,055 $389,000
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $75,464 - $112,383	-800 Reduced 28.57%	2,000 $238,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $54,119 - $69,522	-637 Reduced 18.53%	2,800 $268,000
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $32,268 - $40,675	-437 Reduced 11.28%	3,437 $316,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $22,765 - $28,366	297 Added 8.3%	3,874 $297,000
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $3,956 - $6,274	73 Added 2.08%	3,577 $300,000
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $173,272 - $220,051	3,504 New	3,504 $206,000

490

53.8M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.69B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.